Tevogen Bio Holdings Announces 2025 Annual Meeting
Ticker: TVGNW · Form: DEFA14A · Filed: Apr 25, 2025 · CIK: 1860871
| Field | Detail |
|---|---|
| Company | Tevogen Bio Holdings Inc. (TVGNW) |
| Form Type | DEFA14A |
| Filed Date | Apr 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-filing, annual-meeting
Related Tickers: TIVO
TL;DR
Tevogen Bio (TIVO) filed proxy for 2025 annual meeting. Shareholders vote soon.
AI Summary
Tevogen Bio Holdings Inc. filed a DEFA14A on April 25, 2025, announcing its 2025 Annual Meeting. The filing is a definitive proxy statement soliciting material under Rule 240.14a-12, indicating it contains information for shareholders regarding the meeting and related matters. No fee was required for this filing.
Why It Matters
This filing informs shareholders about the upcoming annual meeting, which is a crucial event for corporate governance and allows shareholders to vote on important company matters.
Risk Assessment
Risk Level: low — This is a routine proxy filing for an annual meeting and does not contain new financial information or significant corporate actions.
Key Players & Entities
- Tevogen Bio Holdings Inc. (company) — Registrant
- Semper Paratus Acquisition Corp (company) — Former company name
- 0001641172-25-006291 (filing_id) — Accession Number
FAQ
What is the purpose of this DEFA14A filing?
The purpose of this DEFA14A filing is to serve as a definitive proxy statement soliciting material for the 2025 Annual Meeting of Tevogen Bio Holdings Inc., as indicated by the filing under Schedule 14A Information and Rule §240.14a-12.
When was this filing made?
This filing was made on April 25, 2025.
What was Tevogen Bio Holdings Inc. formerly known as?
Tevogen Bio Holdings Inc. was formerly known as Semper Paratus Acquisition Corp, with a date of name change on May 5, 2021.
Is there a filing fee associated with this document?
No, the filing indicates 'No fee required'.
What is the business address of Tevogen Bio Holdings Inc.?
The business address of Tevogen Bio Holdings Inc. is 15 Independence Boulevard, Suite 410, Warren, NJ 07059.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 25, 2025 regarding Tevogen Bio Holdings Inc. (TVGNW).